S. Spiro (Middlesex, United Kingdom), R. M. Huber (Munich, Germany), B. Grigoriu (Iasi, Romania)
Patients with a lung cancer are changed: About a French monocentric cohort between 1990 and 2010
F. Vaylet, J. Margery, I. N‘Gampolo, W. Gaspard, A. Mairovitz, H. Le Floch, F. Riviere, F. Pons, J. P. Arigon, R. Jancovici, P. Saint Blancard, C. Marotel, P. L‘Her (Clamart, France)
|  |
Increased survival in lung cancer patients with diabetes mellitus: A large cohort study
P. Hatlen, B. H. Grønberg, A. Langhammer, S. M. Carlsen, T. Amundsen (Trondheim, Verdal, Norway)
|  |
Lung cancer in patients with COPD: Incidence and predicting factors
J. de Torres, J. Marin, C. Casanova, C. Cote, S. Carrizo, E. Cordoba Lanus, R. Baz Davila, J. Zulueta, A. Aguirre Jaime, M. Saetta, M. Cosio, B. Celli (Pamplona, Tenerife, Zaragoza, Spain; New York, Boston, United States Of America; Padova, Italy; Montreal, Canada)
| |
COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer?
D. Tofolean, L. Mazilu, T. Adam, A. I. Suceveanu, P. Iorga, I. T. Tofolean (Constanta, Bucharest, Romania)
| |
Pecularities of lung cancer in patients with COPD
O. Lukina, A. Speranskaya, A. Hristolubov, A. Litvinov, V. Trofimiov (Saint-Petersburg, Russian Federation)
| |
Epidemiological and histologic features of lung cancer in Montenegro
M. Medenica, N. Perosevic (Niksic, Podgorica, Republic Of Serbia)
| |
Occupational exposure to carcinogens and lung cancer: Impact of a dedicated professional disease consultation in a Belgian oncologic centre
A. P. Meert, I. Morelle, T. Berghmans, I. C. S. Toth, J. P. Sculier (Brussels, Belgium)
| |
The association between residential radon concentration and lung cancer
D. A. Todea, L. E. Rosca, C. Cosma, T. Dicu (Cluj Napoca, Romania)
| |
Is female gender a protective factor for NSCLC patients? A follow up study of 20 years of 478 patients
J. Chatkin, N. Scaglia, J. Figueiredo-Pinto (Porto Alegre, Brazil)
| |
A retrospective study of lung cancer in young patients
P. Rajagopalan, D. G. Price, S. Sasikumar, R. Baghai Ravary, N. R. Goldsack, B. Pereira (Canterbury, United Kingdom)
| |
KRAS mutations in non-small cell lung cancer (NSCLC) – Experiences by routine molecular testing in a German lung cancer centre
C. Boch, J. Kollmeier, D. Misch, A. Roth, T. Blum, W. Gruening, N. Schoenfeld, T. Mairinger, T. T. Bauer (Berlin, Germany)
| |
Characterization of patients with non-small cell lung cancer (NSCLC) relative to its EGFR mutational status
A. Castro, A. Antunes, A. Barroso, S. Conde, S. Neves, B. Parente (Vila Nova de Gaia, Portugal)
| |
Analysis of EGFR-mutations in a diverse urban patient population
A. Tufman, K. Wagner, A. Jung, R. M. Huber (Munich, Germany)
| |
Comparison of the clinico-pathological profile of bronchogenic carcinoma among smokers and never-smokers
S. Ambur, A. Shet, G. D‘Souza (Bangalore, India)
| |
In lung cancer screening by CT incidental findings are frequent and often of clinical importance
Z. Saghir, A. Dirksen, J. H. Pedersen (Hellerup, Copenhagen, Copenhagen, Denmark)
| |
Evaluation of the effect of sampling of spontaneous sputum over a prolonged period on the sensitivity for lung cancer
J. Hubers, D. Heideman, J. Herder, S. Burgers, P. Sterk, P. Kunst, H. Smit, P. Postmus, S. Duin, P. Snijders, G. Meijer, E. Smit, E. Thunnissen (Amsterdam, Nieuwegein, Netherlands)
| |
Molecular test supporting early lung cancer detection project based on pilot Pomeranian lung cancer screening program
A. Szymanowska-Narloch, R. Dziadziuszko, M. Jelitto-Gorska, W. Rzyman (Gdansk, Poland)
| |
Current screening programs for lung cancer – Are inclusion criteria too rigorous to identify asymptomatic patients?
A. Bugge, A. Naalsund, M. B. Lund (Oslo, Norway)
| |
A study of design an original questionnaire for evaluating risks of lung cancer
B. Chen, D. Wang, W. Li, D. Liu (Chengdu, China)
| |
Effects of the self-evaluation scoring questionnaire and chest digital radiography in lung cancer screening: A three-year follow-up study
B. Chen, Y. Wang, D. Liu, W. Li (Chengdu, China)
| |